This site centralizes resources for governments for the introduction and successful roll-out of COVID-19 vaccines, as well as resources for the general public to answer questions related to COVID-19 vaccines.
COVID-19 Vaccination in the Americas – Toolkit
- XXVII Meeting of º£½ÇÉçÇø's Technical Advisory Group (TAG) on Vaccine-Preventable Diseases: Tailoring the SAGE Roadmap to the Requirements of the Americas and the Strategic Use of COVID-19 Booster Doses, 27 January 2022 (virtual meeting)
- XXVI Meeting of º£½ÇÉçÇø’s Technical Advisory Group (TAG) on Vaccine-Preventable Diseases. Vaccines bring us closer, 14–16 July 2021 (virtual meeting)
- Sixth ad hoc Meeting of º£½ÇÉçÇø's Technical Advisory Group (TAG) on Vaccine-preventable Diseases. USA, 16 November 2020 (virtual meeting)
- Fifth ad hoc Meeting of the Technical Advisory Group (TAG) on Vaccine-preventable Diseases, 4 August 2020, USA (virtual meeting)
- Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines v 2020
- COVID-19 Vaccine Country Readiness Assessment Tool (VIRAT)
- Guidelines to Plan for COVID-19 Vaccine Introduction, Version: July 2020
- Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines v 2021 (new)
- New!
- Guide for the preparation of a risk communication strategy for COVID-19 vaccines: A Resource for the countries of the Americas
- Community needs, perceptions, and demand: community assessment tool
- Conducting community engagement for COVID-19 vaccines: Interim guidance
- Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance
- Acceptance and demand for COVID-19 vaccines: Interim guidance
- Acceptance and demand for COVID-19 vaccines: communications plan template
- Partner Resource: UNICEF Vaccine Misinformation Management Guide
- Communication in Crises Related to Vaccine Safety: Technical Guidance
- Communicating about Vaccine Safety: Guidelines to help health workers communicate with parents, caregivers, and patients
- Health worker communication for COVID-19 vaccination flow diagram
- How to talk about vaccines
- Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness
- Recommendations for verifying information about COVID-19 vaccines. A guide for journalists.
- Communicating with a focus on equity, gender and cultural diversity in the framework of access to vaccination against COVID-19. Practical Guide (available only in Spanish)
- ±Ê´Ú¾±³ú±ð°ù–B¾±´Ç±·°Õ±ð³¦³ó COVID-19 vaccine: Interim recommendations and more information
- Moderna mRNA-1273 vaccine: Interim recommendations and more information
- AstraZeneca and Oxford University Vaccine: Interim Recommendations and more information
- Janssen Ad26.COV2.S COVID-19 vaccine: Interim guidance and more information
- Sinopharm inactivated COVID-19 vaccine BIBP: Interim recommendations and more
- Sinovac CoronaVac COVID-19 vaccine: Interim Recommendations and more information
- Bharat Biotech BBV152 COVID-19 vaccine: Interim Recommendations and more information
- CanSinoBIO COVID-19 vaccine: Interim recommendations and more information
- Valneva VLA2001 COVID-19 vaccine: Interim recommendations and more information
- Novavax NVX-CoV2373 COVID-19 vaccine: Interim recommendations and more information
Explainers
Job Aids
:: FAQs
- Technical Document: Frequently Asked Questions (FAQs) about COVID-19 Vaccines
- General Public: Frequently Asked Questions on COVID-19 vaccines
- Ten Things Healthcare Workers Need to Know about COVID-19 Vaccines
- Addressing COVID-19 Vaccine Myths
- Key Messages and Answers about Vaccine Safety: Manual for Health care workers
- Questions and Answers: COVID-19 vaccines and pregnancy
COVID-19 vaccine: Interim recommendations and more information
Videos of interest
